Magrath D I
WHO, Geneva, Switzerland.
Vaccine. 1992;10(13):952-3. doi: 10.1016/0264-410x(92)90331-d.
In establishing standards of quality for vaccines used in vaccination programmes, it is necessary to protect the recipients without demanding unnecessarily high specifications and standards of purity. Such standards reduce profitability, jeopardizing further vaccine supplies and future research, and also diminish the probability of vaccine manufacture outside the industrialized countries. Funds will be needed to encourage research and local manufacture, and internationally accepted procedures of quality assurance must be established.
在为疫苗接种计划中使用的疫苗制定质量标准时，有必要在不要求过高纯度规格和标准的情况下保护接种者。这样的标准会降低盈利能力，危及未来的疫苗供应和研究，还会减少工业化国家以外地区生产疫苗的可能性。需要资金来鼓励研究和本地生产，并且必须建立国际认可的质量保证程序。
